JPRN-UMIN000015017
Completed
Phase 1
Amniotic membrane-derived mesenchymal stromal cells for the treatment of steroid-resistant acute GVHD - Amnion MSC for GVHD
Hematology Division, Internal Medicine, Hyogo college of Medicine0 sites5 target enrollmentSeptember 8, 2014
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hematology Division, Internal Medicine, Hyogo college of Medicine
- Enrollment
- 5
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1 patients with Liver damage other than GVHD (Total bililubin \>2\.0mg/dl or AST and/or ALT\>200U/L 2 patients with Serum creatinine \>2mg/dl 3 patients with allergy to bovine or porcine products 4 patienst with relapsed at MSC infusion 5 patients with uncontrolled infection 6 blood O2 saturation \<94% even 3L/min Oxygen supply 7 Patients attending physician has determined ineligible.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
mbilical cord-derived mesenchymal stromal cells therapy for SARS-CoV-2 infection (COVID-19) related Acute Respiratory Distress SyndromeJPRN-jRCT1080225369Human Life CORD Japan Inc.12
Completed
Phase 1
Exosomes Derived from placental Mesenchymal Stem Cells as Treatment for Severe COVID-19: Phase 1 & 2 Clinical TrialsAcute Respiratory Distress Syndrome of COVID-19.COVID-19U07.1IRCT20200413047063N2Omid Cell and Tissue center50
Completed
Not Applicable
Development of placenta decidual stromal cellPregnancy, childbirth and the puerperiumKCT0002761The Catholic University of Korea, Seoul St. Mary's Hospital10
Active, not recruiting
Not Applicable
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 18.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2015-001560-19-DKDepartment of Cardiology, Rigshospitalet
Not yet recruiting
Phase 1
Amnion cells for COVID-19 related respiratory failureCOVID-19 related respiratory failureRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesACTRN12620000676910Monash Health40